GEQZX
Price
$62.28
Change
+$0.52 (+0.84%)
Updated
Jul 3 closing price
Net Assets
5.37B
VITSX
Price
$150.04
Change
+$1.28 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

GEQZX vs VITSX

Header iconGEQZX vs VITSX Comparison
Open Charts GEQZX vs VITSXBanner chart's image
GuideStone Funds Equity Index Investor
Price$62.28
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets5.37B
Vanguard Total Stock Market Idx I
Price$150.04
Change+$1.28 (+0.86%)
VolumeN/A
Net Assets1.82T
GEQZX vs VITSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GEQZX vs. VITSX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEQZX is a StrongBuy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. GEQZX (5.37B). VITSX pays higher dividends than GEQZX: VITSX (1.22) vs GEQZX (0.89). GEQZX was incepted earlier than VITSX: GEQZX (24 years) vs VITSX (28 years). GEQZX (0.39) is less costly to investors than VITSX (0.03). GEQZX is a more actively managed with annual turnover of: 4.00 vs. VITSX (2.00). GEQZX has a lower initial minimum investment than VITSX: GEQZX (1000) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 13.90 vs. GEQZX (11.58). VITSX return over 5 years is better than : 95.64 vs. GEQZX (88.91).
GEQZXVITSXGEQZX / VITSX
Total Expense Ratio0.390.031,300%
Annual Report Gross Expense Ratio0.390.031,300%
Fund Existence24 years28 years-
Gain YTD6.8956.423107%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.37B1.82T0%
Annual Yield % from dividends0.891.2273%
Returns for 1 year11.5813.9083%
Returns for 3 years59.3262.1295%
Returns for 5 years88.9195.6493%
Returns for 10 years200.23198.64101%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
GIB106.190.93
+0.88%
CGI
PSMT106.610.06
+0.06%
PriceSmart